Related references
Note: Only part of the references are listed.Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
Mark I. James et al.
CANCER LETTERS (2015)
Metastatic Colorectal Cancer: Current State and Future Directions
Marwan G. Fakih
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Curcumin Combined with Oxaliplatin Effectively Suppress Colorectal Carcinoma in vivo Through Inducing Apoptosis
Li-da Guo et al.
PHYTOTHERAPY RESEARCH (2015)
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
Alba Gines et al.
PLOS ONE (2015)
Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs
Temesgen Samuel et al.
BMC CANCER (2014)
Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
Zhongwei Cao et al.
CANCER CELL INTERNATIONAL (2014)
Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray
M. S. Reimers et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest
Ying-Ti Wang et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2014)
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
Sahdeo Prasad et al.
CANCER RESEARCH AND TREATMENT (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins
Piroska Virag et al.
BMC GENOMICS (2013)
Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration-A Clinical Pilot Study Including Assessment of Patient Acceptability
Glen R. B. Irving et al.
CANCER PREVENTION RESEARCH (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways
Mehdi Shakibaei et al.
PLOS ONE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2
Peter H. Killian et al.
CARCINOGENESIS (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
Yan Ning et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism
Smitha V. Bava et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo
Lynne M. Howells et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Functional Genomics Reveals Diverse Cellular Processes That Modulate Tumor Cell Response to Oxaliplatin
Kelly A. Harradine et al.
MOLECULAR CANCER RESEARCH (2011)
Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin
Tanvi S. Jani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eran Eden et al.
BMC BIOINFORMATICS (2009)
NF-kappa B Signaling Pathway, Inflammation and Colorectal Cancer
Soly Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
The role of chemokines in intestinal inflammation and cancer
Dingzhi Wang et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
Anna Martinez-Cardus et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX
Yingjie Yu et al.
TRANSLATIONAL ONCOLOGY (2009)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-kappa B Transcription and Evasion of Apoptosis
Catherine Wilson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-IR
Bhaumik B. Patel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Curcumin downregulates the inflammatory cytokines CXCL1 and-2 in breast cancer cells via NF kappa B
Beatrice E. Bachmeier et al.
CARCINOGENESIS (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Role of curcumin in cancer therapy
Shishir Shishodia et al.
CURRENT PROBLEMS IN CANCER (2007)
Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines
Lynne M. Howells et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Discovering motifs in ranked lists of DNA sequences
Eran Eden et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
Anthony D. Yang et al.
CLINICAL CANCER RESEARCH (2006)
NF-κB and IKK as therapeutic targets in cancer
HJ Kim et al.
CELL DEATH AND DIFFERENTIATION (2006)
被撤回的出版物: Curcumin (diferuloylmethane) inhibits constitutive active NF-κB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells (Retracted article. See vol. 129, pg. 2762, 2011)
M Tomita et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma
S Shishodia et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Use of within-array replicate spots for assessing differential expression in microarray experiments
GK Smyth et al.
BIOINFORMATICS (2005)
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
DJ Brat et al.
NEURO-ONCOLOGY (2005)
Interleukin-8 induces nuclear transcription factor-κB through a TRAF6-dependent pathway
SK Manna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Enhanced radiosensitization and chemosensitization in NF-κB-suppressed human oral cancer cells via the inhibition of γ-irradiation- and 5-Fu-induced production,of Il-6 and Il-8
T Tamatani et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
NF-κB-inducing kinase restores defective IκB kinase activity and NF-κB signaling in intestinal epithelial cells
MP Russo et al.
CELLULAR SIGNALLING (2004)
Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
RA Sharma et al.
CLINICAL CANCER RESEARCH (2004)
Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-κB- and AP-1-dependent mechanism
TS Collins et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
NF-κB activation by camptothecin -: A linkage between nuclear DNA damage and cytoplasmic signaling events
TT Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
